Clinical Trial

The DefiPace Study

Study acronym: Defipace
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, non-interventional, multi-center, international registry in two phases in consecutive patients undergoing elective cardiac surgery. The DefiPace registry is designed in two phases 1. to document the standard of care in 50 patients with atrial fibrillation (AF) 2. to assess the treatment and outcomes of patients with post-operative atrial fibrilllation using low-energy cardioversion and subsequent bi-atrial pacing in clinical practice in 100 patients
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-31 -> 2027-09-30 2026-07-31
minor Completion pushed: 2026-08-31 -> 2027-12-31 2026-07-31
Trial Details
NCT Number NCT04804748
Lead Sponsor Institut für Pharmakologie und Präventive Medizin
Collaborators: Osypka AG
Conditions Post-operative Atrial Fibrillation POAF
Enrollment 450 participants
Start Date 2023-03-28
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30